¼¼°èÀÇ Á¤Çü¿Ü°ú¿ë ¼ºÀå ÀÎÀÚ ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®(2025-2031³â) - MedCore
Orthopedic Growth Factor Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Cervical Disc Degeneration Market, Tibial Fracture Market, and 2 more
»óǰÄÚµå : 1676625
¸®¼­Ä¡»ç : iData Research Inc.
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 40 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 6,828,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,995 £Ü 9,562,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,995 £Ü 12,297,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷(ÇØ¿Ü)ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Á¤Çü¿Ü°ú¿ë ¼ºÀå ÀÎÀÚ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 10¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº 2.2%ÀÇ CAGR·Î È®´ëÇϸç, 2031³â¿¡´Â 12¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

COVID-19 ÆÒµ¥¹Í¿¡ ÀÇÇØ 2020³â¿¡´Â ¼±Åà ¼ö¼ú ĵ½½¿¡ ÀÇÇÑ ÆÇ¸Å °¨¼Ò°¡ ¹ß»ýÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ÀϽÃÀûÀΠȥ¶õ¿¡µµ ºÒ±¸ÇÏ°í ½ÃÀåÀº 2022³â±îÁö °­·ÂÇÏ°Ô È¸º¹µÇ¾î ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼·Î µ¹¾Æ¼¹½À´Ï´Ù.

ôÃß °íÁ¤¼úÀº ¿©ÀüÈ÷ Á¤Çü¿Ü°ú¿ë ¼ºÀå ÀÎÀÚ ¼ºÀåÀÇ Áß¿äÇÑ ¿øµ¿·ÂÀÔ´Ï´Ù. ÇöÀç ÁøÇà ÁßÀÎ ÀÓ»ó ¿¬±¸´Â »À À¯ÇÕ°ú ôÃß Ä¡·á¿¡¼­ ¼ºÀå ÀÎÀÚÀÇ È¿´ÉÀ» ÀÔÁõÇϰí ÀÖ½À´Ï´Ù. ±â¾÷Àº ÀûÀÀÁõ È®´ë¿¡ ´ëÇÑ FDA ½ÂÀÎÀ» ¹Þ°í ÀÖÀ¸¸ç, ÀÌ´Â Á¤Çü¿Ü°ú¿ë ¼ºÀå ÀÎÀÚÀÇ Æø³ÐÀº äÅÃÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÃÖ±Ù ½ÂÀÎÀº °æÃß Ãß°£ÆÇ º¯¼ºÁõ°ú ÇÏÁö/Á·°üÀý °íÁ¤¼ú ºÐ¾ßÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

¼¼°èÀÇ Á¤Çü¿Ü°ú¿ë ¼ºÀå ÀÎÀÚ ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ °³¿ä¿Í ½ÃÀå ºÐ¼®°ú ¿¹Ãø, ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ, °æÀï ±¸µµ µîÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

°³¿ä

¼­·Ð

½Ã¼ú °Ç¼ö

½ÃÀå ºÐ¼®°ú ¿¹Ãø

°Ç¼ö ºÐ¼®

ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ

°æÀï ½ÃÀå Á¡À¯À² ºÐ¼®

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global orthopedic growth factor market was valued at $1.05 billion in 2024 and is projected to grow at a CAGR of 2.2%, reaching $1.2 billion by 2031.

This market is segmented by indication type, including:

Market Insights & Data Coverage

Market Trends

* The COVID-19 pandemic led to a decline in sales due to canceled elective surgeries in 2020.

* Despite this temporary disruption, the market recovered strongly by 2022 and returned to steady growth.

* Spinal fusion remains a key driver of growth for orthopedic growth factors.

* Ongoing clinical research supports the efficacy of growth factors in bone healing and spinal procedures.

* Companies are securing FDA approvals for expanded indications, leading to wider adoption of orthopedic growth factors.

* Recent approvals have fueled growth in the cervical disc degeneration and hindfoot/ankle fusion segments.

Market Share Insights

Top Competitors in the Global Orthopedic Growth Factor Market (2024):

1 Medtronic

* Market leader in the orthopedic growth factor segment.

* INFUSE(R) remains the gold standard for spinal fusion therapies.

2 Cerapedics

* Second-largest market share with its i-Factor(TM) product.

* Expanded FDA approval allows i-Factor(TM) to be used in single-level anterior cervical discectomy fusion (ACDF) with an allograft bone ring or fusion interbody device.

3 Stryker

* Third-largest competitor, known for its AUGMENT(R) product line.

* AUGMENT(R) is the first and only FDA-approved alternative to autograft for hindfoot and ankle arthrodesis.

Market Segmentation Summary

Cervical Disc Degeneration Market

Tibial Fracture Market

Spine Market

Ankle & Hindfoot Fusion Market

Global Research Scope

* North America (U.S., Canada)

* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)

* Western Europe (Germany, France, U.K., Spain, Italy)

* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)

* Middle East (Saudi Arabia, UAE, Israel)

* Asia Pacific (China, Japan, India, South Korea, Australia)

* Africa (South Africa, Egypt, Nigeria, Kenya)

Quantitative Coverage

Qualitative Coverage

Data Sources:

TABLE OF CONTENT

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â